Your browser doesn't support javascript.
loading
Parameters of MR perfusion-weighted imaging predict the response and prognosis to high-dose methotrexate-based chemotherapy in immunocompetent patients with primary central nervous system lymphoma.
Luo, Xiangwei; Zhu, Youzhi; Zhang, Yu; Zhang, Qian; Wang, Xiao; Deng, Xuefei.
Afiliação
  • Luo X; Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, People's Republic of China.
  • Zhu Y; Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, People's Republic of China.
  • Zhang Y; Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, People's Republic of China. Electronic address: zhangyu105fsk@163.com.
  • Zhang Q; Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, People's Republic of China.
  • Wang X; Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei 230031, People's Republic of China.
  • Deng X; School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, People's Republic of China. Electronic address: dengxf@ahmu.edu.cn.
J Clin Neurosci ; 95: 151-158, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34929639

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Neoplasias do Sistema Nervoso Central Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Neoplasias do Sistema Nervoso Central Idioma: En Ano de publicação: 2022 Tipo de documento: Article